Navigation Links
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
Date:2/21/2012

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at four investor conferences in February and March.

2012 Citi Global Healthcare Conference
Onyx will present at the 2012 Citi Global Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time). 

Cowen and Company 32nd Annual Health Care Conference
Onyx will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012 at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time). 

24th Annual ROTH Conference
Onyx will present at the 24th Annual ROTH Conference on Monday, March 12, 2012 at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time). 

Barclays Capital Global Healthcare Conference
Onyx will present at the Barclays Capital Global Healthcare Conference on Tuesday, March 13, 2012 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time). 

Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx.com/investors/event-calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.  For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through the following dates:

  • 2012 Citi Global Healthcare Conference - March 12, 2012
  • Cowen and Company 32nd Annual Health Care Conference - March 21, 2012
  • 24th Annual ROTH Conference – March 26, 2012
  • Barclays Capital Global Healthcare Conference – March 27, 2012

 

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
2. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
3. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
4. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
5. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
6. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
7. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
8. Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
9. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... 19, 2017 Research and Markets has announced ... Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, ... ... global market is projected to reach $15,737 million by 2022 from ... to 2022. Omic technologies segment accounted for more ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
Breaking Biology Technology:
(Date:1/6/2017)... NEWARK, Calif. , Jan. 5, 2017  Delta ... introduced its iris scanning technology for automotive at CES® ... GNTX ) to demonstrate the use of ... to identify and authenticate the driver in a car, ... automobiles during the driving experience. Delta ID ...
(Date:12/22/2016)... 2016  As part of its longstanding mission to improve ... company, recently released its latest children,s book, titled ... on the topics of inheritance and variation of traits that ... in elementary school classrooms in the US. ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
Breaking Biology News(10 mins):